Aberdeen Asset Management’s Globus Medical GMED Stock Holding History

Aberdeen Asset Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$60.1M	Sell	1,813,865 -72,722	-4%	-$2.28M	0.2%	89
2017 Q1	$55.9M	Sell	1,886,587 -523,908	-22%	-$14.3M	0.2%	82
2016 Q4	$59.8M	Buy	2,410,495 +424,620	+21%	+$9.65M	0.23%	74
2016 Q3	$44.8M	Buy	1,985,875 +214,456	+12%	+$5.04M	0.16%	89
2016 Q2	$42.2M	Buy	1,771,419 +570,635	+48%	+$13.7M	0.16%	95
2016 Q1	$28.5M	Buy	1,200,784 +384,309	+47%	+$9.39M	0.1%	138
2015 Q4	$17.5M	Buy	816,475 +413,773	+103%	+$10.4M	0.06%	201
2015 Q3	$8.32M	Buy	402,702 +107,102	+36%	+$2.71M	0.03%	293
2015 Q2	$7.59M	Buy	295,600 +168,200	+132%	+$4.26M	0.02%	319
2015 Q1	$3.22M	Buy	+127,400	New	+$3.1M	0.01%	461

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return

Aberdeen Asset Management's GMED Position: Q2 2017 in Review

Aberdeen Asset Management reduced its Globus Medical (GMED) stake by 3.9% in Q2 2017, selling an estimated $2.28M and leaving 1,813,865 shares worth $60.1M. The position accounts for 0.2% of the portfolio, ranked #89.

Aberdeen Asset Management first reported a position in GMED in Q1 2015 and has held it in 10 quarters since. 244 funds tracked by Wall St. Rank hold GMED as of Q2 2017.

Aberdeen Asset Management held 1,813,865 shares of Globus Medical worth $60.1M as of Q2 2017.
Aberdeen Asset Management sold 72,722 Globus Medical shares in Q2 2017, an estimated $2.28M.
Globus Medical made up 0.2% of Aberdeen Asset Management's portfolio in Q2 2017, its #89 holding.
Aberdeen Asset Management first reported a position in Globus Medical in Q1 2015 and has held it in 10 quarters since.
244 funds tracked by Wall St. Rank held Globus Medical as of Q2 2017.

Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.